Most behavioral health practice owners either overestimate or underestimate their practice’s value — often by 30—50%. The overestimators set unrealistic price expectations that derail negotiations. The underestimators accept offers well below market value because they didn’t know better.
This guide gives you the actual framework buyers use to value behavioral health practices across all sub-verticals: ABA therapy, mental health groups, addiction treatment, and outpatient behavioral health. It also includes a quick self-assessment so you can score your practice before you speak to a single buyer.
The Baseline: How Buyers Calculate Practice Value
Before diving into the five factors, understand the core valuation math.
The EBITDA multiple method is the dominant valuation framework for behavioral health practices generating $1M+ in annual revenue. The formula is simple:
Practice Value = Adjusted EBITDA Ã Multiple
Adjusted EBITDA is your practice’s earnings after adding back owner compensation above market rate, personal expenses, depreciation, and one-time items. The multiple is determined by the market — and by how your specific practice scores on the five factors below.
For smaller practices (under $1M annual revenue), buyers often use a revenue multiple or a gross receipts approach — typically 0.5x—1.5x annual gross revenue, depending on practice profitability and transferability.
Current market ranges for behavioral health EBITDA multiples:
- ABA therapy: 4x—7x
- Mental health group practices: 3x—6x
- Addiction treatment (residential): 5x—8x
- Addiction treatment (outpatient): 4x—6x
- Outpatient behavioral health (mixed): 3x—5.5x
[LINK: See the full EBITDA multiple table with 2026 market data — /behavioral-health-ebitda-multiples]
Factor 1: Revenue Quality (Payer Mix)
What buyers are assessing: Whether your revenue is durable, collectible, and reimbursed at rates that generate sustainable margin.
Payer mix is the single most impactful factor on behavioral health practice value — more than size, more than geography. Why? Because two practices with identical EBITDA can have radically different values based on how that EBITDA was generated.
High-value payer characteristics:
- Commercial insurance at contracted rates (BlueCross, Aetna, Cigna, UnitedHealth)
- Self-pay or private-pay at full rate (typically $150—$300+ per session in mental health)
- Value-based contracts with quality bonuses
Value-suppressing payer characteristics:
- Medicaid at floor reimbursement rates
- Single-payer concentration (40%+ from one commercial payer)
- High EAP volume (typically lower rates, time-limited authorizations)
- Unverified self-pay or chronic patient balance issues
Self-assessment questions:
- What percentage of your revenue is commercial insurance?
- Is any single payer more than 35% of your collections?
- Are your Medicaid rates within 10% of the state average, or below?
- Have any payers audited or recouped payments in the last 24 months?
Score this factor: Commercial-dominant (65%+ commercial) = High. Balanced (40—65% commercial) = Medium. Medicaid-dominant or heavily concentrated = Low.
Why Medicaid Concentration Suppresses Value
Medicaid rates in behavioral health vary significantly by state. In states where Medicaid rates are within 10—15% of commercial rates, Medicaid volume is manageable. In states with large rate disparities (common in rural and Southeastern markets), Medicaid-heavy practices may be structurally low-margin even at high revenue volumes — and buyers will price that in.
Factor 2: Clinical Staff Stability
What buyers are assessing: Whether the clinical revenue engine survives the ownership transition.
This is the “key-person risk” factor. In behavioral health, the clinical staff — BCBAs, licensed therapists, counselors, psychiatrists — are the practice. If they leave post-close, the practice’s revenue leaves with them.
High-value staff profile:
- Low voluntary turnover rate (<20% annually for licensed staff)
- Average staff tenure >2 years for clinical leads
- No owner-operator clinical dependency (owner is manager, not primary clinician)
- Employment agreements with reasonable non-solicitation provisions
- Documentation of supervision structures that comply with licensing board requirements
Value-suppressing staff scenarios:
- Owner is primary or sole clinician
- Multiple vacancies in licensed staff roles at time of sale
- High turnover history (>35% annually) without identifiable cause and correction
- No non-compete or non-solicitation agreements with senior clinicians
- Credentialing gaps in staff files
Self-assessment questions:
- If you left the practice tomorrow, what percentage of revenue would be at risk within 90 days?
- What is your average annual turnover rate for licensed clinical staff?
- Do your senior clinicians have employment agreements in place?
Score this factor: Low owner dependency, high tenure, agreements in place = High. Moderate dependency, average tenure = Medium. Owner is primary clinician, high turnover = Low.
[LINK: How BCBA staff retention specifically affects ABA practice valuations — /aba-therapy-practice-valuation]
Factor 3: Compliance, Accreditation, and Regulatory Status
What buyers are assessing: Whether they’re acquiring a clean regulatory history or inheriting liability.
This factor has become increasingly decisive in larger transactions — and it can kill deals or trigger significant price reductions when problems surface.
High-value compliance profile:
- CARF or Joint Commission accreditation (especially for addiction treatment and outpatient programs)
- Clean HIPAA audit history; documented privacy practices
- No outstanding licensing board complaints or investigations against the practice or key staff
- Medicaid/Medicare billing compliance program in place; no recoupment demands in past 24 months
- Up-to-date state licensing for all applicable program categories
- OSHA compliance documentation (if applicable)
Value-suppressing compliance scenarios:
- Active or recently resolved licensing board investigations
- Medicaid billing audit with outstanding recoupment demands
- HIPAA breach history without documented remediation
- Unresolved billing disputes with commercial payers
- Scope-of-practice concerns (staff performing services outside their licensed scope)
Accreditation impact on multiples: CARF accreditation adds 0.25x—0.75x to the EBITDA multiple for addiction treatment centers, and increasingly for mental health programs as well. Joint Commission accreditation has similar impact. For ABA practices, BHCOE (Behavioral Health Center of Excellence) accreditation is beginning to carry meaningful weight with PE buyers.
Self-assessment questions:
- Is your practice CARF, Joint Commission, or BHCOE accredited?
- Have you had any licensing board complaints in the past 5 years?
- When was your last billing compliance review?
Score this factor: Accredited, clean history = High. No accreditation, clean history = Medium. Active issues or audit history = Low.
Factor 4: Facility and Lease Quality
What buyers are assessing: Whether the physical infrastructure supports practice continuity and growth post-acquisition.
Facility and lease factors are often overlooked by sellers, but they can materially impact deal timing, financing, and price.
High-value facility profile:
- Lease with 3+ years remaining at close, or renewal options clearly documented
- Lease assignment rights (most commercial leases require landlord consent for assignment to a new owner — verify this before going to market)
- Space appropriate for current capacity and near-term growth
- ADA compliant
- Clinical environment appropriate to your service lines (private rooms for therapy, appropriate sensory environment for ABA)
Value-suppressing facility scenarios:
- Lease expiring within 12 months with no renewal executed
- Lease with no assignment clause or landlord known to resist assignment
- Below-code or non-ADA-compliant facility
- Lease at materially above-market rates with long remaining term (increases operating cost baseline)
Self-assessment questions:
- How many years remain on your primary lease?
- Does your lease allow assignment to a buyer without additional consent?
- Is your facility in a location that supports your target client demographics?
Score this factor: 3+ year lease, assignment rights, good location = High. Short remaining term, renewal pending = Medium. Lease expiring, no assignment rights = Low.
Factor 5: Geographic Market and Competitive Position
What buyers are assessing: Whether the market supports continued growth and whether the practice has a defensible position in it.
A great practice in a declining or oversaturated market is worth less than a comparable practice in a high-demand, supply-constrained geography.
High-value market characteristics:
- MSA with documented population growth and high behavioral health demand indicators
- Limited competition from PE-backed platform operators already in market (fresh territory = strategic value)
- Proximity to referral sources: PCPs, pediatricians, hospitals, courts (for addiction treatment), schools (for ABA)
- State regulatory environment favorable to behavioral health reimbursement
Value-suppressing market scenarios:
- Rural geography with declining population
- Market already saturated with PE-backed competitors (limits growth and may reduce buyer pool)
- State with adverse Medicaid rate history or pending program cuts
- Geographic isolation that limits referral network access
Self-assessment questions:
- Is your MSA growing or declining in population?
- Are there PE-backed platforms already operating in your market?
- What are your top three referral sources, and how reliable are those pipelines?
Score this factor: Growth market, strong referral network, differentiated position = High. Stable market, average referrals = Medium. Declining market, heavy competition = Low.
Quick Self-Assessment Framework: Score Your Practice
Rate each factor High (2 points), Medium (1 point), or Low (0 points):
| Factor | Your Score |
|---|---|
| Revenue Quality (Payer Mix) | ___/2 |
| Clinical Staff Stability | ___/2 |
| Compliance & Accreditation | ___/2 |
| Facility & Lease | ___/2 |
| Geographic Market | ___/2 |
| Total | ___/10 |
Interpreting your score:
- 8—10: Your practice is positioned for top-quartile valuations. You are likely in the upper range of the multiple spectrum for your sub-vertical.
- 5—7: Your practice has real value with identifiable areas for improvement. Address low-scoring factors before going to market to maximize proceeds.
- 0—4: Significant work needed before a sale process. Consider a 12—24 month value improvement plan before engaging buyers.
This self-assessment is a starting point. A professional valuation will incorporate financial modeling, buyer market data, and transaction comps that a self-assessment cannot capture.
Frequently Asked Questions: Behavioral Health Practice Value
How much is a behavioral health practice worth?
Behavioral health practices typically sell for 3x to 8x adjusted EBITDA, depending on the sub-vertical, practice size, and quality factors. ABA therapy practices command 4x—7x; mental health groups 3x—6x; addiction residential 5x—8x. Smaller practices may be valued at 0.5x—1.5x annual gross revenue.
What is the most important factor in behavioral health practice value?
Payer mix is typically the single most impactful factor, because it directly determines EBITDA margin. However, clinical staff stability is a close second — particularly for practices where the owner is also the primary clinical provider. Both must be strong to support a premium multiple.
Does CARF accreditation increase my practice’s sale price?
Yes. CARF accreditation typically adds 0.25x—0.75x to the EBITDA multiple for behavioral health practices, particularly addiction treatment and outpatient behavioral health programs. It signals regulatory compliance, clinical quality, and operational maturity — all of which reduce buyer-perceived risk.
How far in advance should I start preparing to sell my behavioral health practice?
Ideally, 12—24 months in advance. This allows time to address valuation suppressors (short lease, low payer mix, staff retention gaps), clean up financials, pursue accreditation if not yet achieved, and execute the practice growth that turns into a higher EBITDA basis at valuation.
Does practice size affect the EBITDA multiple I’ll receive?
Yes — larger practices consistently command higher multiples. This is sometimes called the “size premium.” A $10M ABA practice will typically receive a meaningfully higher multiple than a $2M ABA practice, even if both are well-run. This is because larger practices have more management depth, lower key-person risk, and more attractive scalability for PE buyers.
Can I increase my practice’s value before selling?
Yes — meaningfully so. The highest-leverage improvements are: (1) diversifying payer mix toward commercial, (2) executing non-compete/retention agreements with key clinical staff, (3) pursuing CARF or relevant accreditation, (4) renewing your lease with assignment rights, and (5) building 12—18 months of clean, growing EBITDA trajectory.
Should I get a valuation before deciding whether to sell?
Yes. A professional valuation gives you a market-based anchor for decision-making, identifies specific value drivers to improve, and prepares you for buyer conversations. Behavioral Health Business Broker offers confidential valuations at no cost to qualified practice owners.
[LINK: Deep dive on ABA therapy practice valuation — /aba-therapy-practice-valuation]
[LINK: Step-by-step guide to selling a mental health practice — /how-to-sell-mental-health-practice]
[LINK: See what addiction treatment centers sell for — /addiction-treatment-center-acquisition]
[LINK: Full EBITDA multiples table by sub-vertical — /behavioral-health-ebitda-multiples]